Team
Pipeline
Ophthalmology
Metabolic Disease
Neurology
Ophthalmology
Metabolic Disease
Neurology
Platform
Manufacturing
Product Design
Research & Development
Manufacturing
Product Design
Research & Development
Newsroom
Careers
Newsroom
Search
Search
September 6, 2023
Kriya Acquires Tramontane Therapeutics and Launches Gene Therapy Program for Nonalcoholic Steatohepatitis (NASH) and Other Prevalent Diseases
: Kriya Acquires Tramontane Therapeutics and Launches Gene Therapy Program for Nonalcoholic Steatohepatitis (NASH) and Other Prevalent Diseases
July 26, 2023
Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases
: Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases
May 2, 2023
Kriya to Present 10 Abstracts at the 2023 American Society of Gene and Cell Therapy Annual Meeting
: Kriya to Present 10 Abstracts at the 2023 American Society of Gene and Cell Therapy Annual Meeting
November 16, 2022
Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio
: Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio
August 25, 2022
Kriya Appoints Curt Herberts as President and Chief Operating Officer
: Kriya Appoints Curt Herberts as President and Chief Operating Officer
May 16, 2022
Kriya Announces $270 Million Series C Financing to Advance Fully Integrated Gene Therapy Engine
: Kriya Announces $270 Million Series C Financing to Advance Fully Integrated Gene Therapy Engine
January 26, 2022
Kriya Licenses Next Generation Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseases
: Kriya Licenses Next Generation Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseases
July 28, 2021
Kriya Therapeutics Completes Renovation of its Facility for Scalable Gene Therapy Manufacturing
: Kriya Therapeutics Completes Renovation of its Facility for Scalable Gene Therapy Manufacturing
July 14, 2021
Kriya Therapeutics Completes $100 Million Series B Financing to Advance its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies
: Kriya Therapeutics Completes $100 Million Series B Financing to Advance its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies
Previous
1
2
3
Load More
